Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202800
Status:
COMPLETED
Last Update Posted:
2023-06-02
First Post:
2005-09-12
Brief Title:
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Sponsor:
Spectrum Health Hospitals
Organization:
Spectrum Health Hospitals
Organization Data
Organization:
Spectrum Health Hospitals
Class:
OTHER
Study ID:
VARI-002-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spectrum Health Hospitals
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Marianne Lange MD
Old Organization:
Spectrum Health
Collaborators
| Name | Class |
|---|---|
| Saint Marys Health Network | OTHER |
| Van Andel Research Institute | OTHER |
| Eli Lilly and Company | INDUSTRY |
| Battle Creek Health System | OTHER |
| Mercy Health System | NETWORK |
| Metropolitan Hospital Michigan | OTHER |
| Mecosta County General Hospital | UNKNOWN |
| Munson Medical Center | OTHER |